rotenone and h 89
rotenone has been researched along with h 89 in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Brownlee, M; Du, XL; Edelstein, D; Guzmán, M; Kaneda, Y; Yamagishi , SI | 1 |
Chen, SD; Fan, GH; Qi, C; Wang, G; Zhou, HY | 1 |
Gao, XF; He, C; Wang, W | 1 |
Other Studies
5 other study(ies) available for rotenone and h 89
Article | Year |
---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A.
Topics: Acetyl-CoA Carboxylase; Animals; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carrier Proteins; Cattle; Cells, Cultured; Chemokine CCL2; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Electron Transport; Endothelium, Vascular; Fatty Acids; Genistein; Glucose; Humans; Ion Channels; Isoquinolines; Leptin; Liposomes; Membrane Proteins; Metalloporphyrins; Mitochondria; Mitochondrial Proteins; Oxidation-Reduction; Reactive Oxygen Species; Rotenone; Sulfonamides; Superoxide Dismutase; Superoxides; Thenoyltrifluoroacetone; Uncoupling Protein 1 | 2001 |
PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone.
Topics: Animals; Bucladesine; Caspase 3; Caspases; Cell Differentiation; Cell Survival; Colforsin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Intracellular Membranes; Isoquinolines; MAP Kinase Signaling System; Membrane Potentials; Mitochondria; Nerve Growth Factors; Neurons; Neuropeptides; Neurosecretory Systems; Neurotransmitter Agents; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; PC12 Cells; Pituitary Adenylate Cyclase-Activating Polypeptide; Protein Kinase Inhibitors; Rats; Rotenone; Signal Transduction; Sulfonamides | 2005 |
Rotenone inhibits delayed rectifier K+ current via a protein kinase A-dependent mechanism.
Topics: Animals; Cells, Cultured; Colforsin; Cyclic AMP-Dependent Protein Kinases; Delayed Rectifier Potassium Channels; Electrophysiology; Isoquinolines; Membrane Potentials; Neurons; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Inwardly Rectifying; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Rotenone; Signal Transduction; Sulfonamides; Uncoupling Agents | 2008 |